Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Unibio presents pioneering venture in the alternative protein industry - worth over $1 trillion

Unibio presents pioneering venture in the alternative protein industry - worth over $1 trillion

Unibio CEO David Henstrom joins Proactive London's Katie Pilbeam to talk about their pioneering venture in the biotechnology sector with core competences within fermentation technologies.

Unibio International was incorporated in 2014, and its 100% owned subsidiary company was incorporated in 2001.

The company owns the rights to a unique fermentation technology – the U-Loop® technology – which has been developed in cooperation with DTU and is the result of more than 30 years of research and development activities.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK